Main > A1. CORP. INDEX. A-Am No. 1 > Allergan Inc./P C2 > R&D>Collaborations C2 > Sirna Therapeutics Inc.

---

to develop Sirna-027, a novel RNAi-based therapeutic currently in clinical trials for age-related macular degeneration and to discover and develop other novel RNAi-based therapeutics against select gene targets for ophthalmic diseases.



Sirna Therapeutics Inc.'s products
This section has no products